• Home
  • Search Results

Search Results

374 studies match your search
Open

Drug that may help Cutaneous Lupus Erythematosus

Do you have Cutaneous Lupus Erythematosus (CLE)? If you have tried antimalarials but they haven't helped your skin get better, you may be able to take part in a research study. In this study, we want to find out if a new drug improves the skin of patients with CLE. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Chronic Conditions
  • Skin, Hair, and Nails
Open

Sitting Interruption Study

Do you have cardiovascular disease risk factors? Do you sit too much? Help researchers learn more about the most effective strategy for interrupting sitting! If you are 45 years or older, you may be able to take part in a research study to find out if interrupting sitting with walking or pedaling reduces cardiovascular disease risk.

Age & Gender
  • 45 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Blood Pressure
  • Diabetes
  • and 9 more
Open

An Open-label, Multicenter Study of LOXO-435 in Advanced Solid Tumor Malignancies with FGFR3 Alterations

Have you been diagnosed with cancer and either your cancer did not respond to treatment or your cancer progressed? If so, you may be able to take part in a research study evaluating the safety of an investigational treatment called LOXO-435 in cancer patients.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Other Cancers)
Open

A Phase 3 Trial in Metastatic Untreated Renal Cell (Kidney) Cancer [Nivolumab and Ipilimumab Followed by Nivolumab vs. Cabozantinib with Nivolumab]

Have you been diagnosed with Kidney Cancer? If so, you may be able to take part in a research study comparing a drug called cabozantinib to another treatment after receiving standard of care treatment in patients.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Kidney)
  • Kidneys and Liver
Open

Nutrition for Precision Health - Tailored Nutrition Study

Nutrition is not one-size-fits-all. Nutrition, or the foods we eat, can help prevent and fight conditions such as high blood pressure, diabetes, stroke, and more. However, we all live in different environments, we come from different cultures, and each of us is starting from a different place with our health. Additionally, everyone breaks down food differently. Join the Nutrition for Precision Health research study to help researchers learn how our genes, cultural backgrounds, and environments affect our bodies' responses to food. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Open

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Do you have endometrial cancer? ]. If so, you may be able to take part in a research study looking at the safety of giving a combination treatment of the drugs ONC201 plus Atezolizumab to patients with endometrial cancer.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))
Open

Women's Health Study

We are looking for women between the ages of 18-45 to join a national health study to help us understand the impact of HIV on women's lives and bodies. Both women living with HIV and women without HIV are invited to take part.

Age & Gender
  • 18 years ~ 45 years
  • Female
Study Interest
  • Behavior
  • Healthy Volunteer or General Population
  • Pregnancy
  • and 4 more
Open

NRG-GI008 - Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Have you been diagnosed with colon cancer? If so, you may be able to take part in a research study looking to find out what kind of chemotherapy to recommend to patients based on the presence or absence of circulating tumor DNA (ctDNA) after surgery for colon cancer and if this approach is better or worse than the usual approach for your colon cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Colorectal)
Open

Nutrition, Eating, and Mealtimes for Older Adults with Myelodysplastic Syndromes and Acute Myeloid Leukemia, and their Care Partners

Have you been recently diagnosed with Acute Myeloid Leukemia or Myelodysplastic Syndromes? If you are 60 years or older and you are scheduled to receive treatment with hypomethylating agents and Venetoclax, you and your care partner may be able to take part in a research study. In this study, we want to understand nutrition, eating, and mealtimes for people with these cancers. Compensation provided.

Age & Gender
  • 60 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Blood Conditions
  • Cancer (Leukemia)
  • Eating, Nutrition, and Metabolism
Open

A092104: Testing olaparib and temozolomide versus the usual treatment for uterine leiomyosarcoma after chemotherapie

Do you have uterine leiomyosarcoma that has grown after initial treatment with two prior forms of chemotherapy and cannot be removed by surgery? if so you may be able to take part in a research study to find out if the combination of olaparib and temozolomide is better, worse or the same than the usual approach for advanced uterine leiomyosarcoma.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research